focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,132.00
Bid: 12,130.00
Ask: 12,132.00
Change: -34.00 (-0.28%)
Spread: 2.00 (0.016%)
Open: 12,186.00
High: 12,198.00
Low: 12,116.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 6-PM Johnson says UK in 'race against time' as it faces worst weeks of pandemic

Mon, 11th Jan 2021 07:42

* "Very perilous moment", Johnson says

* Hospitals running out of oxygen

* Dangerous time ahead for health service - medical adviser

* UK has vaccinated 2 million so far

* People must stick to lockdown rules, Johnson says
(Adds UK vaccination plan)

By Michael Holden

LONDON, Jan 11 (Reuters) - Prime Minister Boris Johnson said
on Monday Britain was in "a race against time" to rollout
COVID-19 vaccines as deaths hit record highs and hospitals run
out of oxygen, with his top medical adviser saying the
pandemic's worst weeks were imminent.

A new, more transmissible variant of the disease is now
surging through the population, with one in 20 people in parts
of London now infected, threatening to overwhelm the health
service with hospitals overloaded with patients.

The death toll in the United Kingdom has been soaring and
now stands in excess of 81,000 - the world's fifth-highest toll
- while more than 3 million people have tested positive.

In a bid to get on top of the pandemic and to try to restore
some degree of normality by the spring, Britain is rushing out
its largest ever vaccination programme, with shots to be offered
to about 15 million people by the middle of next month.

"It's a race against time, because we can all see the threat
that our NHS faces, the pressure it's under, the demand in
intensive care units, the pressure on ventilated beds, even the
shortage of oxygen in some places," Johnson said on a visit to a
vaccination centre in Bristol, in southwest England.

"This is a very perilous moment. The worst thing now for us
is to allow success in rolling out a vaccine programme to breed
any kind of complacency about the state of the pandemic."

The government's chief medical adviser Chris Whitty had
earlier warned the situation was set to deteriorate.

"The next few weeks are going to be the worst weeks of this
pandemic in terms of numbers into the NHS (National Health
Service)," he told BBC TV.

"Anybody who is not shocked by the number of people in
hospital who are seriously ill at the moment and who are dying
over the course of this pandemic, I think, has not understood
this at all. This is an appalling situation," he told BBC TV.

"DANGEROUS TIME"

During the peak of the first outbreak in April, about 18,000
people were in hospital but now there are 30,000, Whitty said,
describing it as "the most dangerous time we've really had in
terms of numbers".

Johnson's government is pinning its hopes on a mass
vaccination programme after Britain became the first country to
approve vaccines developed by Oxford-AstraZeneca and by
Pfizer/BioNTech , and approved Moderna's
shot on Friday.

Its plan, announced on Monday, envisages 2 million shots
being delivered at some 2,700 centres a week in England by the
end of January, with the aim of immunising tens of millions of
people by the spring and all adults offered a vaccine by the
autumn.

Johnson said 2 million people had already been given the
vaccine - more than any other European country - but admitted
that inoculating 15 million people in the four highest risk
levels, including those over 70 and frontline health workers, by
a Feb. 15 target was "a huge ask".

"We believe it's achievable, we're going throw absolutely
everything at it, to get it done," he said.

Opposition Labour leader Keir Starmer, who has repeatedly
accused Johnson of being too slow to respond to the pandemic,
said the prime minister's indecision had cost lives and worsened
the economic impact

"We shouldn’t be facing the slowest recovery and we
shouldn’t be suffering the tragedy of so many deaths every day
from this virus," he said.

Ministers and health chiefs have pleaded with people to
respect lockdown measures and stay at home, amid fears some
people are not adhering to the rules strictly enough, along with
concern that the virus is being spread in supermarkets.

"Where we have to tighten them, we will," Johnson said of
the rules.
(Additional reporting by Guy Faulconbridge, Kate Holton,
William Schomberg, Paul Sandle and James Davey; writing by
Michael Holden; editing by Estelle Shirbon, Guy Faulconbridge
and Angus MacSwan)

More News
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.